CES 2026, Sumbu announced its Exo-S3 line of dual-vector exoskeletons designed for the general public: the Exo-S3, Exo-S3 Pro and Exo-S3 Ultra. The series is the world’s first commercially available ...
Partnership accelerates AGC Biologics' leadership in the AAV market, applying its BravoAAVâ„¢ platform to complex gene therapies for inherited blindness MILAN--(BUSINESS WIRE)-- On the heels of ...
Exo-S3 lineup brings AI-powered, lightweight leg assistance to the market LAS VEGAS, Jan. 3, 2026 /PRNewswire/ -- Today at CES 2026, Sumbu announced its Exo-S3 line of dual-vector exoskeletons ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback